Optimal treatment of rhabdomyosarcoma (RMS) requires multidisciplinary approach,
incorporating chemotherapy with local control. Although current therapies are built on …

Rhabdomyosarcoma, the most common soft tissue sarcoma noted in childhood, requires
multimodality treatment, including chemotherapy, surgical resection, and/or radiation …

Rhabdomyosarcoma is the most common sarcoma of childhood. Fortunately, the goal of
cure is realistic for the majority of patients with localized tumors. However, management of …

Rhabdomyosarcoma is a typical tumor of childhood and adolescence. Over the years there
has been a gradual but important improvement in survival for patients with this tumor …

What is new in the biology and treatment of pediatric rhabdo... : Current Opinion in Pediatrics
What is new in the biology and treatment of pediatric rhabdomyosarcoma? : Current Opinion in …

During the past 2 decades, several different multidisciplinary treatment studies of childhood
rhabdomyosarcoma have been conducted, some as single-institution protocols and others …

Rhabdomyosarcoma is the most common childhood soft tissue sarcoma and the fourth most
common pediatric solid tumor. For most patients, treatment consists of a multimodality …

Rhabdomyosarcoma (RMS) is a malignant childhood tumor of mesenchymal origin that
currently has a greater than 70% overall 5-year survival. Multimodality treatment is …

Simple Summary Due to their rarity, we still know comparatively little about
rhabdomyosarcomas (RMS) in adolescents and young adults (AYA). Factors responsible for …

Rhabdomyosarcoma (RMS) is a rare type of soft tissue sarcoma that mainly affects children,
but also occurs in adolescents and (young) adults (AYA). Despite dramatic survival …